Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Aquilina, G.
Right arrow Articles by Bignami, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aquilina, G.
Right arrow Articles by Bignami, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 12, 2317-2326, December 1999
© 1999 Oxford University Press


Carcinogenesis

Mismatch repair, G2/M cell cycle arrest and lethality after DNA damage

Gabriele Aquilina3, Marco Crescenzi3,1 and Margherita Bignami2

Laboratory of Comparative Toxicology and Ecotoxicology, Section of Chemical Carcinogenesis, Istituto Superiore di Sanita', Viale Regina Elena 299, 00161 Roma, Italy and
1 Laboratory of Molecular Oncogenesis, Regina Elena Cancer Institute, 00161 Roma, Italy

The role of the mismatch repair pathway in DNA replication is well defined but its involvement in processing DNA damage induced by chemical or physical agents is less clear. DNA repair and cell cycle control are tightly linked and it has been suggested that mismatch repair is necessary to activate the G2/M checkpoint in the presence of certain types of DNA damage. We investigated the proposed role for mismatch repair (MMR) in activation of the G2/M checkpoint following exposure to DNA-damaging agents. We compared the response of MMR-proficient HeLa and Raji cells with isogenic variants defective in either the hMutL{alpha} or hMutS{alpha} complex. Different agents were used: the cross-linker N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea (CCNU), {gamma}-radiation and the monofunctional methylating agent N-methyl-N-nitrosourea (MNU). MMR-defective cells are relatively sensitive to CCNU, while no differences in survival between repair-proficient and -deficient cells were observed after exposure to {gamma}-radiation. Analysis of cell cycle distribution indicates that G2 arrest is induced at least as efficiently in MMR-defective cells after exposure to either CCNU or ionizing radiation. As expected, MNU does not induce G2 accumulation in MMR-defective cells, which are known to be highly tolerant to killing by methylating agents, indicating that MNU-induced cell cycle alterations are strictly dependent on the cytotoxic processing of methylation damage by MMR. Conversely, activation of the G2/M checkpoint after DNA damage induced by CCNU and {gamma}-radiation does not depend on functional MMR. In addition, the absence of a simple correlation between the extent of G2 arrest and cell killing by these agents suggests that G2 arrest reflects the processing by MMR of both lethal and non-lethal DNA damage.

Abbreviations: CCNU, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea; FCS, fetal calf serum; ICL, interstrand DNA cross-links; MMR, mismatch repair; MMR, MMR-defective; MMR+, MMR-proficient; MNNG, N-methyl-N'-nitro-N-nitrosoguanidine; MNU, N-methyl-N-nitrosourea; O6-meGua, O6-methylguanine; 6-TG, 6-thioguanine.

2 To whom correspondence should be addressed Email: bignami{at}iss.it

3 The first two authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
B. Cui, S. P. Johnson, N. Bullock, F. Ali-Osman, D. D. Bigner, and H. S. Friedman
Bifunctional DNA Alkylator 1,3-Bis(2-chloroethyl)-1-nitrosourea Activates the ATR-Chk1 Pathway Independently of the Mismatch Repair Pathway
Mol. Pharmacol., June 1, 2009; 75(6): 1356 - 1363.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J Barwell, L Pangon, S Hodgson, A Georgiou, I Kesterton, T Slade, M Taylor, S J Payne, H Brinkman, J Smythe, et al.
Biallelic mutation of MSH2 in primary human cells is associated with sensitivity to irradiation and altered RAD51 foci kinetics
J. Med. Genet., August 1, 2007; 44(8): 516 - 520.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. O'Brien and R. Brown
Signalling cell cycle arrest and cell death through the MMR System
Carcinogenesis, April 1, 2006; 27(4): 682 - 692.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
B. Trouiller, D. G. Schaefer, F. Charlot, and F. Nogue
MSH2 is essential for the preservation of genome integrity and prevents homeologous recombination in the moss Physcomitrella patens
Nucleic Acids Res., January 5, 2006; 34(1): 232 - 242.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Bohon and C. R. de los Santos
Effect of 6-thioguanine on the stability of duplex DNA
Nucleic Acids Res., May 19, 2005; 33(9): 2880 - 2886.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Peterson-Roth, M. Reynolds, G. Quievryn, and A. Zhitkovich
Mismatch Repair Proteins Are Activators of Toxic Responses to Chromium-DNA Damage
Mol. Cell. Biol., May 1, 2005; 25(9): 3596 - 3607.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
M. K. Zubko, S. Guillard, and D. Lydall
Exo1 and Rad24 Differentially Regulate Generation of ssDNA at Telomeres of Saccharomyces cerevisiae cdc13-1 Mutants
Genetics, September 1, 2004; 168(1): 103 - 115.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L. Stojic, N. Mojas, P. Cejka, M. di Pietro, S. Ferrari, G. Marra, and J. Jiricny
Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase
Genes & Dev., June 1, 2004; 18(11): 1331 - 1344.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Papouli, P. Cejka, and J. Jiricny
Dependence of the Cytotoxicity of DNA-Damaging Agents on the Mismatch Repair Status of Human Cells
Cancer Res., May 15, 2004; 64(10): 3391 - 3394.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. S. Kandel, J. Skeen, N. Majewski, A. Di Cristofano, P. P. Pandolfi, C. S. Feliciano, A. Gartel, and N. Hay
Activation of Akt/Protein Kinase B Overcomes a G2/M Cell Cycle Checkpoint Induced by DNA Damage
Mol. Cell. Biol., November 15, 2002; 22(22): 7831 - 7841.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Yan, J. E. Schupp, H.-s. Hwang, M. W. Wagner, S. E. Berry, S. Strickfaden, M. L. Veigl, W. D. Sedwick, D. A. Boothman, and T. J. Kinsella
Loss of DNA Mismatch Repair Imparts Defective cdc2 Signaling and G2 Arrest Responses without Altering Survival after Ionizing Radiation
Cancer Res., November 1, 2001; 61(22): 8290 - 8297.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.